We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Kansas Federal Judge Rules EpiPen Class Action Can Move Forward
Kansas Federal Judge Rules EpiPen Class Action Can Move Forward
A Kansas federal judge has certified two classes in an antitrust suit against Pfizer and Mylan over an alleged scheme to raise the price of EpiPen (epinephrine injection USP).
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor